chrisvoncsefalvay/vaers-outcomes huggingface dataset:
TROUBLE BREATHING; NECK PAIN; BLURRY VISION; DIARRHEA; DIZZINESS; COUGH; FEEL SICK; WEAKNESS; NAUSEA; ALLERGIES; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included she had no history of allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: 13/JUN/2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced allergies. On 11-APR-2021, the subject experienced cough. On 11-APR-2021, the subject experienced feel sick. On 11-APR-2021, the subject experienced weakness. On 11-APR-2021, the subject experienced nausea. On 13-APR-2021, the subject experienced diarrhea. On 13-APR-2021, the subject experienced dizziness. On 15-APR-2021, the subject experienced neck pain. On 15-APR-2021, the subject experienced blurry vision. On 17-APR-2021, the subject experienced trouble breathing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from weakness, dizziness, neck pain, blurry vision, trouble breathing, cough, allergies, nausea, diarrhea, and feel sick. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Palpable nodule remains at injection site close to one month after administration.  Client complains of pain with certain arm movements.
Became ill in the evening following vaccine, fever, chills, vomiting, cough.  Symptoms subsided the next morning and then body began to break out in hives (Urticaria).  This continued daily for approximately one week then subsided with over the counter antihistamine treatment.  Upon second does, again violantly ill at night post shot,  - Have had Chronic Urticaria since second vaccine on 4/14/2021 as well as swelling of the lips and face periodically.
BODY ACHE; BAD CONGESTION; CHILLS; HEADACHE; FEVER/ FELT WARM; This spontaneous report received from a consumer concerned a 47 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no previous medical history.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 25-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-JUL-2021, the subject experienced body ache. On 02-JUL-2021, the subject experienced bad congestion. On 02-JUL-2021, the subject experienced chills. On 02-JUL-2021, the subject experienced headache. On 02-JUL-2021, the subject experienced fever/ felt warm. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body ache, chills, fever/ felt warm, bad congestion, and headache. This report was non-serious.
Hearing a horn or beeping sounds like things like he has been exposed to loud noise/sound.; Headache,having extreme headache.; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Hearing a horn or beeping sounds like things like he has been exposed to loud noise/sound.) and HEADACHE (Headache,having extreme headache.) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A (could be 025821A) and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (Hearing a horn or beeping sounds like things like he has been exposed to loud noise/sound.) and HEADACHE (Headache,having extreme headache.). The patient was treated with IBUPROFEN for Headache and Ear ringing, at an unspecified dose and frequency and IBUPROFEN for Headache and Ear ringing, at a dose of 1 dosage form. At the time of the report, TINNITUS (Hearing a horn or beeping sounds like things like he has been exposed to loud noise/sound.) and HEADACHE (Headache,having extreme headache.) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow-up received included severity of event were updated.
Mouth broke out in multiple (approx 6) fever blisters that night. By Saturday, 10/24/09 had approx 4 more blisters appears inside and outside of the mouth.
Patient had previously received a Johnson and Johnson covid vaccine. She came in for a routine appointment and decided that she would like a to receive her covid vaccine booster dose. She chose the Moderna. When we administered the vaccination, the Medical Assistant drew up and administered 0.5mL instead of 0.25mL dose for the booster. No harm was done to the patient.
Cannot lift arm past shoulder or extend without extreme pain. He can pinpoint the exact point that is causing pain. Advised to call doctor.
Covid-19 Infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 Infection) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Before the vaccines were available.). Concomitant products included SIMVASTATIN for Cholesterol, ALPRAZOLAM for an unknown indication.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19 Infection). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) in June 2022 for COVID-19 treatment, at a dose of 20 milligram once a day. At the time of the report, COVID-19 (Covid-19 Infection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No adverse event was reported after taking statin drug and paxlovid together. Company comment This spontaneous case reported by a patient, concerns an 83-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious AESI of COVID-19 infection, after receiving the 3rd dose of mRNA-1273 vaccine. Vaccination date and event onset date are unknown, thus, exact latency between vaccination and onset of the event could not be assessed. It was reported that the patient was treated with Nirmatrelvir, Ritonavir (Paxlovid) for COVID-19 treatment. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case reported by a patient, concerns an 83-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious AESI of COVID-19 infection, after receiving the 3rd dose of mRNA-1273 vaccine. Vaccination date and event onset date are unknown, thus, exact latency between vaccination and onset of the event could not be assessed. It was reported that the patient was treated with Nirmatrelvir, Ritonavir (Paxlovid) for COVID-19 treatment. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Afer vaccine I felt numbness of finger tips, That night I had extreme chills,  I have in the last 2 weeks felt numbness of feet, finger tips, weakness in legs,  excess saliva.  I have not sought health care , as I keep telling myself it is my  imagination , or I am hyper  ventilating, I did not have these sensations prior to the vaccine, date. I do have chronic DJD in the back, that flares up  now and then.   I am also an RN at this clinic/
This spontaneous report as received from a registered nurse refers to a 40 year old patient. On 29-OCT-2018, the patient was inadvertently vaccinated with a dose of PROQUAD (route and lot # not reported) and a dose of VARIVAX (dose, route and lot # not reported) instead of VARIVAX and M-M-R II. No adverse effects were reported.
Fever, sites red, warm- LT is quarter size 1/2 size. Red swollen RT (DTaP- HIB) dime size red rash on face and back a little. No redness before.
This case was reported by a pharmacist via call center representative and described the occurrence of mobility decreased in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced mobility decreased and pain in arm. On an unknown date, the outcome of the mobility decreased and pain in arm were unknown. It was unknown if the reporter considered the mobility decreased and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporting pharmacist noted his pharmacy did not give the vaccine to the patient and it was unknown if it was the 1st or 2nd dose of SHINGRIX.   The patient had trouble getting her arm above her head due to the pain. This case was linked with US2019034282, reported by the same reporter.
Tingling in arms/legs. Pt is 20 wks pregnant Narrative:  Vitals: 1524 BP: 136/75, P: 91, T: 98.3, R: 14, O2@100% RA Vitals: 1531 BP: 145/81, P: 87, R: 14 Vitals: 1537 BP: 127/88, P: 87, R: 14, O2: 100% RA Vitals: 1604 BP: 130/89, P: 75, O2: 100% RA
fever 102.7; muscle pain; generalized fatigue; This is a spontaneous report from a non-contactable nurse (patient). An adult female patient received COVID-19 vaccine (UNSPECIFIED TRADE NAME, lot# EK9231), via an unspecified route of administration on 08Jan2021 07:45 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient was not pregnant. If other vaccine in four weeks: No. Twelve hours after the patient received vaccine on 08Jan2021 20:00, the patient developed fever 102.7, muscle pain and generalized fatigue. All symptoms lasted about 24 hours. The patient underwent lab tests and procedures which included body temperature: 102.7 on 08Jan2021. The patient received treatment ibuprofen (MOTRIN) for all the events. If-covid-prior-vaccination: No. If covid tested post vaccination: No. The outcome of all the events was recovered on 09Jan2021. AE was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.   No follow-up attempts are possible. No further information is expected.
Headache lasting 2-3 days. Top of the head, back of the neck.
This spontaneous report as received from a Health care Worker refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 05-NOV-2015, the patient was vaccinated with improperly stored (Merck) VARIVAX (lot # K010442 EXP date: 22-JUL-2016) (dose, route, therapy type not reported). No adverse symptoms were reported. This case is one of two reports received from the same reporter. Additional information has been requested.
Pt. Had vasovagal response immediately after vaccination. Patient was laid down on floor,legs were elevated, pt.felt better, A&Ox3. Transferred pt. To wheel chair, had another vasovagal for 4secods, recovered quickly, emesis pouch was provided , no emesis.had another vasovagal for 3 seconds, quickly pt.laid down to floor. Legs elevated. Ice pack was placed behind neck. Pt. Stayed on floor for 10 mins., recovered, A&oX3. Father at site present whole time. Pt.was moved to observation after She was stable to wait in observation area for 15-30 minutes.
Muscle cramping throughout extremities; arms, hands, legs. Involuntary nerve twitching in elbow and hands/fingers. More pronounced in right arm/hand. Started around 1 pm and did not resolve until the following day.  Residual nerve tenderness in right elbow and wrist.
This spontaneous report as received from a physician refers to a 9 year old male patient (son the reporting physician). The patient's pertinent medical history was not reported. On an unknown date the patient was vaccinated with RECOMBIVAX HB (dose, frequency and route were not reported). On an unknown date, the patient had adverse experiences. The outcome of experienced adverse experiences was unknown. The causality of adverse experiences was not reported. The physician reported that the patient had experienced adverse experiences on a number of unspecified vaccines and RECOMBIVAX HB cannot be ruled out. Additional information is not expected as the reporter details were not reported.
They are here and we found out that they both only have 1 primary series on record from 2021.; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (They are here and we found out that they both only have 1 primary series on record from 2021.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (They are here and we found out that they both only have 1 primary series on record from 2021.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (They are here and we found out that they both only have 1 primary series on record from 2021.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (They are here and we found out that they both only have 1 primary series on record from 2021.).    Concomitant medication was not provided.  Treatment information was not provided.  This case contains information for the 1st patient out of 2 adult patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-719366 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-719366:(Case for Adult Patient 2 )
NUMBNESS, TINGLING, PINS AND NEEDLES, LOSS OF APPETIE, WEIGHT LOSS, NOT STABLE TO WALK NEEDS GUIDANCE , HIGH BLOOD PRESSURE, TEMPORARY PARALYSIS IN THE FACE, SWEATING.SPINAL TAP  RESULTING HIM BEING ADDMITED TO  HOSPITAL DUE TO HAVING  Guillain Barre Syndrome HAVING  TO HAVE IVIG TREATMENT VIA IV FOR 5 DAYS. BECOMING BACKED UP IN BOWELS CAUSING HIM TO THROWUP.
Numbing and tingling almost immediately on my left side, walked the store for 15 minutes got home and began having anaphylactic shock. I took liquid Benadryl to get it to stop. Still have numbing on left side of my body and face.
Pain at injection site. 99 degree F fever. Positive tight chest (or asthma pt not sure).
Patient developed rash on arm surrounding varicella vaccine injection site within a couple days of the vaccine being administered. Within a week, the rash spread from the injection site onto the back. About 6 or 7 red bumps appeared on rash on back that resembled mosquito bites. Two of the bumps became infected and one of them became an abscess the size of a quarter. Doctor was unable to culture the abscess as the fluid was too deep and would have caused patient too much pain. Patient started antibiotics (Keflex) and applied Bactroban cream on spots. Infected spots showed no improvement after 24 hours of antibiotics and patient developed a temperature of 103. New spots also appeared on rash. Patient stopped Keflex and began a different type of antibiotics (Bactrim) and continued using Bactroban cream on spots. The infected spots started improving after about 2 weeks time. The one spot that turned into an abscess took months to fully heal. Ever since then, patient chronically gets red bumps (that resemble the ones which were on the vaccine rash) on various parts of her body which usually clear up with no treatment. A few months later, another bump that turned into an abscess on the back of the patient's thigh became infected and was cultured. The results of the culture came back as Psuedomonas aeruginosa but since very little fluid was obtained, the results were considered inconclusive (although it did come back as a single organism bacterium). About a month later, the same abscess was drained and a considerable amount of fluid was cultured. The results of the culture again came back as Pseudomonas and a single organism bacterium (this abscess again took months to clear up and patient was left with an odd pigmentation where it was that seems permanent). At this point a full workup blood test was given which revealed that patient was neutropenic. Blood tests were repeated at later dates indicating patient is still neutropenic. Patient saw hematologist who diganosed patient with Chronic Benign Neutropenia. Prior to varicella vaccine, patient did not get skin spots recurrently like this and skin spots look exactly like the spots that first showed up on the rash from the vaccine. Patient has not recovered from the neutropenia or the recurrent skin spots as of now (1 year after vaccine), however, the skin spots seem less frequent and patient has not developed any infected skin spots requiring treatment since about 8 months after vaccine was given.
Day 3 cramping in uterus, uteran contractions Day 4 spotting, intense pain and reddish pink discharge  Day 5 bloody discharge turned red and then it turned brown  and continued that way  for a week  and then the next week it started clotting and the bleeding  started again  and continues to this day.
Vomiting at 6:00pm. Lethargic and fever (did not check) at 6:00pm.  Slept all night. 2-20-08 Vomiting started at 7:00am and vomited every couple hours. Lethary continued and fever. Diarrhea started 2-21-08 at 10:00am and 12 noon. Still some fever but drops after Tylenol.  Vomit X 2 so far today.  Worse the first night. No redness or soreness at the site. No treatment yet but encouraged her to call medical provider if continues.
Feel discomfort; Swollen lymph node under arm; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) via an unspecified route of administration in the left arm on 12Mar2021 at 11:00 (at the age of 41-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 02Apr2021 at 11:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient did not have medical history. The patient did not have a history of allergies to medications, food or other products. Concomitant medication taken within two weeks included diazepam; isopropamide iodide (VALTRAX) received on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On unknown date in Mar2021, the patient experienced swollen lymph node under arm where vaccine was administered. It was reported that, after first dose lump appeared 3 to 4 days later and got bigger and experienced discomfort for almost two weeks and still it was a small lump (at the time of this report). On 02Apr2021 after second dose within 8 hours, the patient experienced swollen lymph node. It was reported that lump was swollen, size of baseball and the patient felt discomfort when she put her arm down by side. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events swollen lymph node under arm and feel discomfort were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient reported feeling cold sensation on right arm that quickly radiated up to the right side of her face immediately after receiving vaccine injection on right arm, then felt hot suddenly followed by palpitations.  She denied any chest pain, difficulty breathing, difficulty swallowing or difficulty speaking, dizziness, headache, numbness or tingling to arm or face, vision changes, weakness, pruritus, or any other symptoms.  2:15 PM BP 159/101, HR 110, SPO2 100% on room air.  Patient denied history of anaphylactic reaction or reaction to other vaccines.  She reported she developed delayed injection site reaction 8 days after receiving first dose of Moderna given on 2/26/2021 that included large local reaction on vaccine arm with redness, itching and soreness; she did not report symptoms to any provider and treated at home with Benadryl, symptoms resolved.  Patient reported history of anxiety and panic attacks, denied feeling anxious prior to receiving vaccine today, but felt anxious after experiencing the symptoms post injection.  2:20 PM BP 148/95, HR 108, temp 98.5 F, SPO2 100% room air, patient denied any new symptoms, reported feeling less anxious.  Patient denied history of tachycardia and stated BP within normal for her.  2:23 PM BP 147/93, HR 103.  Patient denied any symptoms.  Patient agreed to be observed for an additional 30 minutes.  2:36 PM BP 147/95, HR 94, SPO2 100%, patient reported feeling well, asymptomatic.  3 PM patient denied any symptom, vitals stable, patient stated feeling well to be discharged home.  Patient discharged home in stable condition.
Had bad chest pain - felt like spasms - started wed 5/26/10 - Thurs 5/27/10 was worse - Fri 5/28/10 it subsided - not stopped. I was away from home - and didn't want to go to strange hospital & doctor.
Joints ache, exhaustion, dizziness, headache, sore-throat, upset-stomach, soreness at injection site and weakness.